D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 45 Citations 9,961 111 World Ranking 3142 National Ranking 1476

Research.com Recognitions

Awards & Achievements

2008 - Member of the National Academy of Medicine (NAM)

Overview

What is she best known for?

The fields of study she is best known for:

  • Acquired immunodeficiency syndrome
  • Virus
  • Internal medicine

Her scientific interests lie mostly in Virology, Virus, Immunology, Acquired immunodeficiency syndrome and Viral disease. Her Virology research integrates issues from Gene and Cohort. Her Virus research is multidisciplinary, relying on both Antibody, Serology and Antigen.

Her Immunology research is multidisciplinary, incorporating elements of Internal medicine, Disease and Clade. Her work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Infectivity, Survival analysis, Epidemiology and Cohort study. In her research on the topic of Viral disease, Generalized lymphadenopathy and Lymphocyte is strongly related with Immunopathology.

Her most cited work include:

  • Isolation of T-cell tropic HTLV-III-like retrovirus from macaques (790 citations)
  • Reduced rate of disease development after HIV-2 infection as compared to HIV-1 (525 citations)
  • Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression (347 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Virology, Acquired immunodeficiency syndrome, Immunology, Virus and Internal medicine. The concepts of her Virology study are interwoven with issues in Antibody and Antigen. She works mostly in the field of Acquired immunodeficiency syndrome, limiting it down to topics relating to Odds ratio and, in certain cases, Logistic regression and Confidence interval, as a part of the same area of interest.

Her research combines Peripheral blood mononuclear cell and Immunology. The Virus study combines topics in areas such as Leukemia, Gene and In vivo. Her research in Internal medicine intersects with topics in Antiretroviral therapy, Viral load and Drug resistance.

She most often published in these fields:

  • Virology (45.86%)
  • Acquired immunodeficiency syndrome (29.32%)
  • Immunology (27.07%)

What were the highlights of her more recent work (between 2013-2021)?

  • Internal medicine (20.68%)
  • Viral load (19.17%)
  • Retrospective cohort study (7.52%)

In recent papers she was focusing on the following fields of study:

Her primary areas of investigation include Internal medicine, Viral load, Retrospective cohort study, Cohort and Pediatrics. Phyllis J. Kanki has included themes like Nevirapine, Efavirenz, Drug resistance and Pharmacology in her Internal medicine study. Viral load is a subfield of Virus that Phyllis J. Kanki tackles.

Phyllis J. Kanki has researched Pediatrics in several fields, including Observational study, Acquired immunodeficiency syndrome, Antiretroviral therapy, Cohort study and Lost to follow-up. Her research in Pregnancy tackles topics such as Transmission which are related to areas like Immunology. Her work in Disease is not limited to one particular discipline; it also encompasses Virology.

Between 2013 and 2021, her most popular works were:

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study (153 citations)
  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis (86 citations)
  • Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study (36 citations)

In her most recent research, the most cited papers focused on:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Virus

Her main research concerns Internal medicine, Regimen, Acquired immunodeficiency syndrome, Viral load and Retrospective cohort study. Her studies deal with areas such as Efavirenz, Drug resistance and Pharmacology as well as Internal medicine. Her Drug resistance research includes themes of Genotypic resistance, HIV drug resistance, First line and Virology.

Her work on NS3 as part of general Virology study is frequently linked to Anthrax toxin, bridging the gap between disciplines. Her Regimen research incorporates themes from Immunology and Zidovudine. Many of her research projects under Acquired immunodeficiency syndrome are closely connected to Quality with Quality, tying the diverse disciplines of science together.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques

Daniel;NL Letvin;NW King;M Kannagi.
Science (1985)

1232 Citations

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

Richard Marlink;Phyllis Kanki;Ibou Thior;Karin Travers.
Science (1994)

779 Citations

Slower heterosexual spread of HIV-2 than HIV-1

P.J. Kanki;K.U. Travers;R.G. Marlink;M.E. Essex.
The Lancet (1994)

474 Citations

Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression

Phyllis J. Kanki;Donald J. Hamel;Jean-Louis Sankalé;Chung-cheng Hsieh.
The Journal of Infectious Diseases (1999)

460 Citations

New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

P J Kanki;F Barin;S M'Boup;J S Allan.
Science (1986)

426 Citations

SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA

F. Barin;F. Denis;J.S. Allan;S. M'Boup.
The Lancet (1985)

380 Citations

Serologic identification and characterization of a macaque T-lymphotropic rétrovirus closely related to HTLV-III

P. J. Kanki;M. F. McLane;N. W. King;N. L. Letvin.
Science (1985)

369 Citations

Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV-1 and HIV-2

Stephen J. Popper;Abdoulaye Dieng Sarr;Karin U. Travers;Aissatou Guèye-Ndiaye.
The Journal of Infectious Diseases (1999)

329 Citations

Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys

PJ Kanki;J Alroy;M Essex.
Science (1985)

283 Citations

A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

Jonathan S. Allan;John E. Coligan;Tun-Hou Lee;Mary Frances McLane.
Science (1985)

279 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Phyllis J. Kanki

Sarah Rowland-Jones

Sarah Rowland-Jones

University of Sheffield

Publications: 60

Ronald C. Desrosiers

Ronald C. Desrosiers

University of Miami

Publications: 55

Luc Montagnier

Luc Montagnier

Institut Pasteur

Publications: 49

Hilton Whittle

Hilton Whittle

University of London

Publications: 47

Eric Delaporte

Eric Delaporte

University of Montpellier

Publications: 41

Martine Peeters

Martine Peeters

Institut de Recherche pour le Développement

Publications: 36

Robert C. Gallo

Robert C. Gallo

University of Maryland, Baltimore

Publications: 35

Thomas C. Quinn

Thomas C. Quinn

National Institutes of Health

Publications: 34

Sophie Matheron

Sophie Matheron

Université Paris Cité

Publications: 33

François Clavel

François Clavel

Inserm : Institut national de la santé et de la recherche médicale

Publications: 31

Joseph Sodroski

Joseph Sodroski

Harvard University

Publications: 31

Gunnel Biberfeld

Gunnel Biberfeld

Karolinska Institute

Publications: 30

Vanessa M. Hirsch

Vanessa M. Hirsch

National Institute of Allergy and Infectious Diseases

Publications: 29

Françoise Brun-Vézinet

Françoise Brun-Vézinet

Université Paris Cité

Publications: 28

Deenan Pillay

Deenan Pillay

University College London

Publications: 28

Peter Aaby

Peter Aaby

Bandim Health Project, Denmark

Publications: 26

Trending Scientists

Lars Tummers

Lars Tummers

Utrecht University

Zhihua Cui

Zhihua Cui

Taiyuan University of Science and Technology

Salim Newaz Kazi

Salim Newaz Kazi

University of Malaya

Rajan Batta

Rajan Batta

University at Buffalo, State University of New York

Michael M. Zavlanos

Michael M. Zavlanos

Duke University

Xiaoyuan Li

Xiaoyuan Li

Yale University

Yong Du

Yong Du

Central South University

John M. Halley

John M. Halley

University of Ioannina

Jens Peter Christensen

Jens Peter Christensen

University of Copenhagen

Martin E.M. Noble

Martin E.M. Noble

Newcastle University

Fred Heffron

Fred Heffron

Oregon Health & Science University

Joseph Cotten

Joseph Cotten

University of Western Brittany

Alma Hodzic

Alma Hodzic

National Center for Atmospheric Research

Thomas F. Schulz

Thomas F. Schulz

Hannover Medical School

Katherine M. Boydell

Katherine M. Boydell

Black Dog Institute

Joseph J. Sabia

Joseph J. Sabia

San Diego State University

Something went wrong. Please try again later.